JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.03% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Financials | 8.61% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5626
Alpha Architect International Quantitative Value ETF
IVAL
$225M
| $48.5K | ﹤0.01% |
1,945
-1,695
| -47% | -$44.2K |
|
|
WCBR
5627
WisdomTree Cybersecurity Fund
WCBR
$122M
| $48.2K | ﹤0.01% |
+1,918
| New | +$46.8K |
|
5628
First Trust Europe AlphaDEX Fund
FEP
$536M
| $48.1K | ﹤0.01% |
1,306
+30
| +2% | +$1.14K |
|
5629
Geospace Technologies
GEOS
$72.4M
| $48.1K | ﹤0.01% |
5,353
-17,661
| -77% | -$199K |
|
|
RGLS
5630
DELISTED
Regulus Therapeutics
RGLS
| $48K | ﹤0.01% |
26,913
+7,171
| +36% | +$16.6K |
|
5631
Priority Technology Holdings
PRTH
$453M
| $48K | ﹤0.01% |
9,089
-20,937
| -70% | -$79.2K |
|
|
GTHX
5632
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $47.9K | ﹤0.01% |
21,029
-33,605
| -62% | -$128K |
|
5633
Design Therapeutics
DSGN
$928M
| $47.5K | ﹤0.01% |
14,184
-24,520
| -63% | -$95.5K |
|
5634
Veru
VERU
$46.5M
| $47.4K | ﹤0.01% |
5,639
+5,630
| +62,556% | +$65.1K |
|
5635
Q32 Bio
QTTB
$451M
| $47K | ﹤0.01% |
2,620
+2,569
| +5,037% | +$61.5K |
|
5636
CALL
Herbalife
HLF
$1.29B
| $46.8K | ﹤0.01% |
+4,500
| New | +$45K |
|
5637
Smartbird Inc
BIRD
$30.1M
| $46.6K | ﹤0.01% |
4,662
-1,832
| -28% | -$22.4K |
|
5638
SKYX Platforms
SKYX
$151M
| $46.6K | ﹤0.01% |
49,079
+22,277
| +83% | +$21.8K |
|
5639
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.08B
| $46.5K | ﹤0.01% |
+622
| New | +$47K |
|
5640
LiveOne
LVO
$57.2M
| $45.9K | ﹤0.01% |
2,924
-3,438
| -54% | -$60.8K |
|
5641
Compass Therapeutics
CMPX
$405M
| $45.9K | ﹤0.01% |
45,883
+7,530
| +20% | +$11K |
|
5642
INmune Bio
INMB
$60.2M
| $45.9K | ﹤0.01% |
+5,202
| New | +$51.3K |
|
5643
Quantum-Si Incorporated
QSI
$161M
| $45.8K | ﹤0.01% |
43,659
+1,377
| +3% | +$2.21K |
|
5644
Taylor Devices
TAYD
$178M
| $45.7K | ﹤0.01% |
+1,015
| New | +$49.2K |
|
5645
Invesco S&P SmallCap Energy ETF
PSCE
$106M
| $45.6K | ﹤0.01% |
868
-43
| -5% | -$2.34K |
|
5646
Direxion Daily Energy Bull 2X ETF
ERX
$251M
| $45.6K | ﹤0.01% |
700
-48
| -6% | -$3.28K |
|
5647
Lifetime Brands
LCUT
$226M
| $45.5K | ﹤0.01% |
5,301
-33,712
| -86% | -$338K |
|
5648
ProShares UltraPro Short Dow 30
SDOW
$186M
| $45.5K | ﹤0.01% |
684
-226
| -25% | -$15.5K |
|
5649
iShares Genomics Immunology and Healthcare ETF
IDNA
$208M
| $45.4K | ﹤0.01% |
1,964
+1,624
| +478% | +$38K |
|
5650
AC Immune
ACIU
$253M
| $45.3K | ﹤0.01% |
11,352
-10,763
| -49% | -$35.6K |
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,512 increased, 3,286 reduced and 579 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 579 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.